Literature DB >> 20398712

Cell delivery therapeutics for musculoskeletal regeneration.

Ulrich Nöth1, Lars Rackwitz, Andre F Steinert, Rocky S Tuan.   

Abstract

The last decade has witnessed the development of cell-based therapy as a major biomedical research area, including the treatment of musculoskeletal diseases. Both differentiated and undifferentiated stem cells have been used as starting cell sources. In particular, the use of multipotent adult mesenchymal stem cells holds great promise for future therapeutic strategies. In addition to the cell type used, the cell delivery system is also of critical importance in cell-based therapy. Cell delivery may be achieved by direct cell injection or by grafting engineered constructs derived by cell seeding into natural or synthetic biomaterial scaffolds. While direct injection is the most direct and convenient means of cell delivery, the latter approach is capable of producing three-dimensional engineered tissues with mechanical properties compatible with those of various musculoskeletal tissues. This review will focus on the functional approach of using biomaterial scaffold materials as cell carriers for musculoskeletal applications, as well as the use of cell-based gene therapy for tissue engineering and regeneration. 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20398712     DOI: 10.1016/j.addr.2010.04.004

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  33 in total

Review 1.  Stem Cells in Skeletal Tissue Engineering: Technologies and Models.

Authors:  Mark T Langhans; Shuting Yu; Rocky S Tuan
Journal:  Curr Stem Cell Res Ther       Date:  2016       Impact factor: 3.828

Review 2.  Cell- and gene-based therapeutic strategies for periodontal regenerative medicine.

Authors:  Hector F Rios; Zhao Lin; Bina Oh; Chan Ho Park; William V Giannobile
Journal:  J Periodontol       Date:  2011-02-02       Impact factor: 6.993

Review 3.  Current status of bone graft options for anterior interbody fusion of the cervical and lumbar spine.

Authors:  Anthony Minh Tien Chau; Lileane Liang Xu; Johnny Ho-Yin Wong; Ralph Jasper Mobbs
Journal:  Neurosurg Rev       Date:  2013-06-07       Impact factor: 3.042

4.  Mesenchymal stem cells derived from vertebrae (vMSCs) show best biological properties.

Authors:  Giovanni Barbanti Brodano; Silvia Terzi; Luisa Trombi; Cristiana Griffoni; Mauro Valtieri; Stefano Boriani; Maria Cristina Magli
Journal:  Eur Spine J       Date:  2013-09-24       Impact factor: 3.134

Review 5.  Barriers to the clinical translation of orthopedic tissue engineering.

Authors:  Christopher H Evans
Journal:  Tissue Eng Part B Rev       Date:  2011-08-08       Impact factor: 6.389

Review 6.  [Cell-based and future therapeutic strategies for femoral head necrosis].

Authors:  L Rackwitz; J C Reichert; M Haversath; U Nöth; M Jäger
Journal:  Orthopade       Date:  2018-09       Impact factor: 1.087

Review 7.  Concise review: the clinical application of mesenchymal stem cells for musculoskeletal regeneration: current status and perspectives.

Authors:  Andre F Steinert; Lars Rackwitz; Fabian Gilbert; Ulrich Nöth; Rocky S Tuan
Journal:  Stem Cells Transl Med       Date:  2012-02-22       Impact factor: 6.940

Review 8.  Controlled release strategies for bone, cartilage, and osteochondral engineering--Part II: challenges on the evolution from single to multiple bioactive factor delivery.

Authors:  Vítor E Santo; Manuela E Gomes; João F Mano; Rui L Reis
Journal:  Tissue Eng Part B Rev       Date:  2013-01-30       Impact factor: 6.389

9.  [Reconstruction of osteochondral defects with a collagen I hydrogel. Results of a prospective multicenter study].

Authors:  L Rackwitz; U Schneider; S Andereya; S Siebenlist; J C Reichert; F Fensky; J Arnholdt; J Arnhold; I Löer; R Grossstück; W Zinser; T Barthel; M Rudert; U Nöth
Journal:  Orthopade       Date:  2012-04       Impact factor: 1.087

Review 10.  Regenerative medicine in 2012: the coming of age of musculoskeletal tissue engineering.

Authors:  Rocky S Tuan
Journal:  Nat Rev Rheumatol       Date:  2013-01-15       Impact factor: 20.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.